help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sauter, G.
Right arrow Articles by Mihatsch, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauter, G.
Right arrow Articles by Mihatsch, M. J.

American Journal of Pathology, Vol 144, 756-766, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization

G Sauter, G Deng, H Moch, R Kerschmann, K Matsumura, S De Vries, T George, J Fuentes, P Carroll and MJ Mihatsch
Department of Laboratory Medicine, University of California, San Francisco.

To understand better the role of physical p53 deletion in bladder cancer, 106 formalin-fixed and 45 unfixed bladder tumors were examined using fluorescence in situ hybridization. Probes for centromere 17 and the p53 locus were hybridized simultaneously to interphase tumor cells to analyze p53 and chromosome 17 copy number on a cell by cell basis. 17p deletion was found in four of 43 pTa tumors, 18 of 43 pT1 tumors and 29 of 58 pT2-4 tumors (P = 0.0001). 17p deletion was also highly correlated with grade (P = 0.0001) and with p53 immunostaining (P = 0.0005). Chromosome 17 polysomy was associated with stage, grade, 17p deletions, and p53 immunostaining (P = 0.0001). The strong difference in centromere 17 copy number and 17p deletions between pTa and pT1 tumors supports a relevant biological distinction between pTa and pT1 tumors.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
R. Terada, T. Yasutake, S. Nakamura, T. Hisamatsu, T. Nakagoe, H. Ayabe, and Y. Tagawa
Evaluation of Metastatic Potential of Gastric Tumors by Staining for Proliferating Cell Nuclear Antigen and Chromosome 17 Numerical Aberrations
Ann. Surg. Oncol., July 1, 2001; 8(6): 525 - 532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
J Nicholson, C Wickramasinghe, F Ross, J Crolla, and D Ellison
Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation
Mol. Pathol., December 1, 2000; 53(6): 313 - 319.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. Hartmann, K. Moser, M. Kriegmair, A. Hofstetter, F. Hofstaedter, and R. Knuechel
Frequent Genetic Alterations in Simple Urothelial Hyperplasias of the Bladder in Patients with Papillary Urothelial Carcinoma
Am. J. Pathol., March 1, 1999; 154(3): 721 - 727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.